Search Results - recombinant rat IgG isot

Palivizumab Biosimilar C021P.05 Syd Labs

Palivizumab Biosimilar, Endotoxin 0.05 EU/mg | C021P.05

Palivizumab Biosimilar, Endotoxin 0.05 EU/mg. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human...

Eculizumab Biosimilar C022P.NA Syd Labs

Eculizumab Biosimilar, N297A Mutant | C022P.NA

Eculizumab Biosimilar, N297A Mutant. Eculizumab biosimilar CHO stable cell line is available for licensing to manufacture the eculizumab biosimilar protein. The research grade eculizumab biosimilar protein is for research use only (RUO). Recombinant human IgG4...

Infliximab Biosimilar C011P.NA Syd Labs

Infliximab Biosimilar, N297A Mutant | C011P.NA

Infliximab Biosimilar, N297A Mutant. Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab biosimilar protein is for research use only (RUO). Recombinant human IgG1...

Tanezumab Biosimilar C110P.NA Syd Labs

Tanezumab Biosimilar, N297A Mutant | C110P.NA

Tanezumab Biosimilar, N297A Mutant. The research grade tanezumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally...